$VAR (Varian Medical Systems, Inc.)

$VAR {{ '2015-06-25T09:25:13+0000' | timeago}} • SEC

$VAR 2Q15 10-Q: At April 3, 2015 (vs. at Sept. 26, 2014): Total assets were $3,459.5MM vs. $3,357.3MM. Total liabilities were $1,781.2MM vs. $1,740.9MM. Borrowings under the 2013 Term Loan Facility totaled $412.5MM, with a WAIR of 1.30%. There was $100MM outstanding on the 2013 Revolving Credit Facility with a WAIR of 1.55%.

$VAR {{ '2017-07-11T12:14:17+0000' | timeago}} • Announcement

$VAR begins advanced breast cancer treatments using Edge radiosurgery system in combination with respiratory gating. The Edge radiosurgery system enables clinicians to attack tumors from outside the body using carefully shaped high-energy X-rays.

$MTD {{ '2017-07-05T13:49:43+0000' | timeago}} • Announcement

$MTD said Elisha Finney has been appointed to its BoD and Audit Committee, effective November 1, 2017. It is anticipated that Finney will succeed Francis Contino as the Chair of the Audit Committee upon his retirement in May 2018. Finney served as the CFO of $VAR.

$VAR {{ '2017-06-29T13:48:54+0000' | timeago}} • Announcement

$VAR has received both FDA 510(k) clearance and CE mark for its Halcyon system, the company's new device for cancer treatment.

$VAR {{ '2017-06-29T13:28:06+0000' | timeago}} • Announcement

$VAR said it received FDA clearance for its cancer treatment device Halcyon, which enhances image-guided volumetric intensity modulated radiotherapy. The system is designed to accelerate installation timeframes, expedite commissioning and automate treatment.

$VAR {{ '2017-06-22T15:41:36+0000' | timeago}} • Announcement

$VAR delivered the cyclotron, a particle accelerator which accelerates protons to two-thirds the speed of light for clinical use, to UK's Christie Proton Therapy Center.

$VAR {{ '2017-06-21T12:39:55+0000' | timeago}} • Announcement

$VAR said it is working with Sify Technologies to provide software-as-a-service (SaaS) to radiotherapy centers across India. The innovative service is being implemented as part of a multi-million dollar investment in treatment equipment and software across Cancer Treatment Services International network of cancer hospitals in India and South Asia.

$VAR {{ '2017-05-24T12:54:52+0000' | timeago}} • Announcement

$VAR said it has been selected through its distributor, Business Alignment, to supply and install a Varian ProBeam Compact single-room proton therapy system in the oncology center at King Chulalongkorn Memorial Hospital in Bangkok, Thailand. First patient treatments are expected to start in 2H19. $VAR is booking order for equipment in 3Q17.

$VAR {{ '2017-05-08T15:52:48+0000' | timeago}} • Announcement

$VAR selected by Proton International to install $VAR ProBeam Compact single-room proton therapy system in a new cancer treatment center on the campus of the Delray Medical Center in Delray Beach, Florida. $VAR is partnering with Proton International for the installations, and first patient treatments are expected to start in Spring 2019.

$VAR {{ '2017-04-26T20:20:54+0000' | timeago}} • Webcast

For 2017, $VAR now expects revenue growth of 2-4%, and EPS of $3.56-3.64, which includes the $0.34 impairment of proton account receivables in 1Q. For second through fourth quarters of FY17, $VAR sees revenue growth of 3-5% and EPS of $2.98-3.06. For 3Q17, $VAR sees revenue growth of about 3% and non-GAAP EPS of of $0.92-0.96.

$VAR {{ '2017-04-26T20:17:43+0000' | timeago}} • Webcast

$VAR reported a drop in 2Q17 earnings due to higher operating expenses and charges from completion of spin-off of Imaging Components business. Net income fell to $56.1MM or $0.60 per share from $97MM or $1.01 per share last year. Revenue grew to $655MM from $615.2MM. Non-GAAP EPS increased to $0.89 from $0.87.

$VAR {{ '2017-04-05T13:10:07+0000' | timeago}} • Announcement

$VAR appointed Gary Bischoping Jr. of Dell Technologies as CFO effective May 8, 2017.  Bischoping will replace Elisha Finney who earlier announced her retirement after serving $VAR for more than 29 years including more than 18 years as its first CFO.

$VAR {{ '2017-04-04T10:45:28+0000' | timeago}} • Announcement

$VAR reached a confidential settlement with Elekta to end its ongoing patent litigation involving technology used for radiation oncology and the treatment of cancer. $VAR and Elekta resolved the disputes in the US, Germany, and the UK, including the suit by Elekta AB and William Beaumont Hospital, with no payments exchanged by the plaintiffs.

$VAR {{ '2017-03-01T16:43:35+0000' | timeago}} • Announcement

$VAR appointed two persons to its BoD, effective March 1, 2017. They are Jose Baselga, Physician-in-Chief at Memorial Sloan Kettering Cancer Center, and Jean-Luc Butel, Senior Adviser to McKinsey Healthcare Practice. They will serve until their re-election or their successors are elected at the next annual meeting of stockholders in 2018.

$VAR {{ '2017-02-09T15:33:57+0000' | timeago}} • Announcement

$VAR won a competitive bid to provide advanced radiotherapy technology and its Eclipse treatment planning system to six major hospitals in Shanghai. The company is scheduled to install its Edge radiosurgery suite in five affiliate hospitals of Shanghai Jiao Tong University this year.

$VAR {{ '2017-01-30T14:55:17+0000' | timeago}} • Announcement

$VAR  has completed the separation of its Imaging Components Business, which is now established as $VREX. The company completed the transaction through distribution of $VREX stock to Varian stockholders of record on Jan. 20, 2017.

$VAR {{ '2017-01-30T14:45:01+0000' | timeago}} • Announcement

For the balance of FY17, $VAR sees revenue from continuing operations growth of 4-5%, bringing revenue growth for the fiscal year to 3-4%. Non-GAAP EPS for second through fourth quarters of FY17 are expected to be $2.94-3.06. For 2Q17, $VAR sees revenue growth of 4-5% and non-GAAP EPS of $0.84-0.90. $VAR plans to repurchase 2MM shares in 2Q17.

$VAR {{ '2017-01-30T14:42:49+0000' | timeago}} • Announcement

Beginning with the company's fiscal 2Q17, $VAR said its Imaging Components segment will be reflected as a discontinued operation for the first four months of FY17, and the company has guided for continuing operations for 2Q through 4Q of FY17.

$VAR {{ '2017-01-30T14:41:32+0000' | timeago}} • Announcement

$VAR appointed Magnus Momsen as SVP and Corporate Controller, replacing Clarence Verhoef, who has assumed the role of CFO for $VREX. Separately, Ruediger Naumann-Etienne and Eric Reinhardt have left the $VAR BoD to join the board of $VREX. $VAR has reduced the number of its board members to 8.

$VAR {{ '2017-01-30T14:40:00+0000' | timeago}} • Announcement

$VAR successfully completed the separation of its Imaging Components Business, which is now established as $VREX. The transaction was completed via a distribution of $VREX stock to $VAR stockholders of record on Jan. 20, 2017.

$VAR {{ '2017-01-25T21:57:58+0000' | timeago}} • Announcement

For FY17, $VAR expects its revenues to grow by 3-4%. Non-GAAP EPS from continuing operating for FY17 is expected to be in the range of $2.94-3.06. For 2Q17, $VAR expects revenues to grow in the range of 4-5% and expects non-GAAP EPS to be in the range of $0.84-0.90.

Recent Transcripts

ISRG (Intuitive Surgical, Inc.)
Thursday, July 20 2017 - 8:30pm
ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
JNJ (Johnson & Johnson)
Tuesday, July 18 2017 - 12:30pm
MDT (Medtronic plc)
Thursday, May 25 2017 - 12:00pm
MCK (McKesson Corporation)
Thursday, May 18 2017 - 9:00pm
ELMD (Electromed, Inc.)
Tuesday, May 16 2017 - 1:00pm
PTX (Pernix Therapeutics Holdings, Inc.)
Monday, May 15 2017 - 8:30pm
KODK (Eastman Kodak Co.)
Tuesday, May 9 2017 - 9:00pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
RMTI (Rockwell Medical, Inc.)
Tuesday, May 9 2017 - 8:30pm
STE (Steris Plc)
Tuesday, May 9 2017 - 2:00pm
NXTM (Nxstage Medical, Inc.)
Tuesday, May 9 2017 - 1:00pm
XRAY (DENTSPLY International Inc.)
Tuesday, May 9 2017 - 12:30pm
ENDP (Endo International plc)
Tuesday, May 9 2017 - 12:30pm
NVAX (Novavax, Inc.)
Monday, May 8 2017 - 8:30pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 9:00pm
REGN (Regeneron Pharmaceuticals, Inc.)
Thursday, May 4 2017 - 12:30pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 12:00pm
IRIX (IRIDEX Corporation)
Wednesday, May 3 2017 - 9:30pm
NVDQ (Novadaq Technologies Inc.)
Wednesday, May 3 2017 - 8:30pm

AlphaGraphics you may like